SEOUL, South Korea–(BUSINESS WIRE)–Hanmi Pharmaceutical Co., Ltd.(KSE: 128940) made an oral presentation on the non-clinical results of once weekly insulin and GLP-1 combination drug ‘LAPSInsulin Combo’ at the 75th American Diabetes Association (ADA) Scientific Session on June 7 in the Boston Convention Center, USA. Hanmi Pharmaceutical presented the possibility of developing a new insulin combination […]

BOSTON, June 7, 2015 /PRNewswire/ — – 166-OR For medical and consumer media in the US only  New phase 3b findings showed adults with type 2 diabetes treated with IDegLira, the investigational once-daily, single-injection combination of insulin degludec and liraglutide in the United States, demonstrated statistically significant reduction in HbA1c (average blood glucose over the […]

BOSTON, June 6, 2015 /PRNewswire-USNewswire/ — From how people test their glucose levels to how long they can expect to live, almost everything has changed over the past 50 years for Americans with diabetes. A special symposium held at the American Diabetes Association’s 75th Scientific Sessions features a look back at what physicians and researchers […]

INDIANAPOLIS, June 6, 2015 /PRNewswire/ — Eli Lilly and Company’s (NYSE: LLY) basal insulin peglispro (BIL) consistently demonstrated superior hemoglobin A1c (HbA1c) reduction in people with type 2 diabetes compared to insulin glargine across three Phase III trials. The results were presented today at the 75th American Diabetes Association (ADA) Scientific Sessions in Boston.1,2,3 The trials […]

PARIS, June 6, 2015 /PRNewswire-USNewswire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that Lyxumia® (lixisenatide) met all co-primary endpoints in a clinical trial (GetGoal Duo-2) comparing its use as a once-daily add-on to basal insulin versus the addition of rapid acting insulin injected once each day at main meal (basal-plus) or three times daily […]

INDIANAPOLIS, June 4, 2015 /PRNewswire/ — Eli Lilly and Company (NYSE:LLY) has committed another 780,000 vials of insulin to the International Diabetes Federation’s Life for a Child program. Life for a Child provides free, life-saving medicine to children living in impoverished communities who otherwise would not have access to the insulin they need. The International […]

HUNTINGTON BEACH, Calif., June 4, 2015 /PRNewswire/ — A new analysis by Life Science Intelligence (LSI), Global Markets for Drug Delivery: Infusion and Injection Technologies in 2015, has concluded that despite efforts to push back on the cost of acquiring new medical devices, innovative drug delivery technologies with higher prices should see greater adoption in […]

Traumatic events during childhood may increase kids’ risk of developing type 1 diabetes, a Swedish study suggests. The researchers questioned more than 10,000 families and found that children who experienced an extremely stressful life event – like divorce, illness or death in the family – were about three times more likely to develop type 1 […]